Decreased microRNA-155 in Behcet’s disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production

Springer Science and Business Media LLC - Tập 23 - Trang 1-11 - 2021
Liang Liang1, Qingyun Zhou1, Lujia Feng1
1The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing Branch of National Clinical Research Center for Ocular Diseases, Chongqing, P. R. China

Tóm tắt

Earlier, we reported that the microRNA (miR)-155 expression in dendritic cells (DCs) from Behcet’s disease (BD) patients was decreased and affected cytokine production of DCs. In this study, we investigated the mechanisms whereby miR-155 regulates cytokine production by DCs. The formation of autophagosomes in DCs was detected by transmission electron microscopy. Western blotting was used to detect the protein levels of LC3, Beclin-1, P62, p-mTOR, and p-Akt in DCs. TNF-α, IL-6, and IL-1β expression were investigated by ELISA. MiR-155 mimics were transfected to DCs to evaluate its effects on autophagy and cytokine production. RNA interference was used to downregulate the expression of TAB2. The formation of autophagosomes was found in DCs of active BD patients. The expressions of LC3-II, Beclin-1, and P62 were significantly increased in DCs of active BD patients compared to that of inactive BD patients and healthy controls. The expressions of IL-6, IL-1β, and TNF-α were significantly increased in DCs of active BD patients compared to that of healthy controls. The autophagy promoter (3-MA) and inhibitor (rapamycin) significantly decreased or increased the expression of TNF-α, IL-6, and IL-1β by DCs. The expression of LC3-II and Beclin-1 was significantly increased, but the expression of P62 proteins was decreased in DCs transfected with miR-155 mimics or after TAB2 was downregulated. The expression of TNF-α, IL-6, and IL-1β was decreased in DCs after miR-155 was upregulated or TAB2 was downregulated. The ratios of p-Akt/Akt and p-mTOR/mTOR were decreased in DCs after miR-155 was upregulated. These results suggest that miR-155 affects the production of TNF-α, IL-6, and IL-1β by DCs through activation of the Akt/mTOR signaling pathway and by affecting the process of autophagy.

Tài liệu tham khảo

Suzuki Kurokawa M, Suzuki N. Behcet’s disease. Clin Exp Med. 2004;4(1):10–20. https://doi.org/10.1007/s10238-004-0033-4.

Bonfioli AA, Orefice F. Behcet’s disease. Semin Ophthalmol. 2005;20(3):199–206. https://doi.org/10.1080/08820530500231953.

Deuter CM, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet’s disease: ocular effects and treatment. Progress Retin Eye Res. 2008;27(1):111–36. https://doi.org/10.1016/j.preteyeres.2007.09.002.

Wang C, Ye Z, Kijlstra A, Zhou Y, Yang P. Activation of the aryl hydrocarbon receptor affects activation and function of human monocyte-derived dendritic cells. Clin Exp Immunol. 2014;177(2):521–30. https://doi.org/10.1111/cei.12352.

He Y, Wang C, Su G, Deng B, Ye Z, Huang Y, et al. Decreased expression of A20 is associated with ocular Behcet’s disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease. Br J Ophthalmol. 2018;102(8):1167–72. https://doi.org/10.1136/bjophthalmol-2017-311707.

Wan CK, He C. Cutting edge: IL-1 receptor signaling is critical for the development of autoimmune uveitis. J Immunol. 2016;196(2):543–6.

Ture-Ozdemir F, Tulunay A, Elbasi MO, Tatli I, Maurer AM, Mumcu G, et al. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet’s disease. Rheumatology (Oxford). 2013;52(5):800–5.

Zhou Q, Xiao X, Wang C, Zhang X, Li F, Zhou Y, et al. Decreased microRNA-155 expression in ocular Behcet’s disease but not in Vogt Koyanagi Harada syndrome. Invest Ophthalmol Vis Sci. 2012;53(9):5665–74. https://doi.org/10.1167/iovs.12-9832.

Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1-2):11–42. https://doi.org/10.1016/j.cell.2018.09.048.

Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12(9):814–22. https://doi.org/10.1038/ncb0910-814.

Boutouja F, Stiehm CM, Platta HW. mTOR: a cellular regulator interface in health and disease. Cells.2019;8(1):18. https://doi.org/10.3390/cells8010018.

Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–62. https://doi.org/10.1056/NEJMra1205406.

Lin DS, Huang YW, Ho CS, Hung PL, Hsu MH, Wang TJ, Wu TY, Lee TH, Huang ZD, Chang PC, et al. Oxidative insults and mitochondrial DNA mutation promote enhanced autophagy and mitophagy compromising cell viability in pluripotent cell model of mitochondrial disease. Cells. 2019;8(1):65. https://doi.org/10.3390/cells8010065.

Ma S, Attarwala I, Xie XS. SQSTM1/p62: a potential target for neurodegenerative disease. ACS Chem Neurosci. 2019;10(5):2094–114. https://doi.org/10.1021/acschemneuro.8b00516.

Lin TA, Wu VC. Autophagy in chronic kidney diseases. Cells. 2019;8(1):61. https://doi.org/10.3390/cells8010061.

Zheng M, Yu H, Zhang L, Li H, Liu Y, Kijlstra A, et al. Association of ATG5 gene polymorphisms with Behcet’s disease and ATG10 gene polymorphisms with VKH syndrome in a Chinese Han population. Invest Ophthalmol Vis Sci. 2015;56(13):8280–7. https://doi.org/10.1167/iovs.15-18035.

Sul OJ, Sung YB, Rajasekaran M, Ke K, Yu R, Back SH, et al. MicroRNA-155 induces autophagy in osteoclasts by targeting transforming growth factor beta-activated kinase 1-binding protein 2 upon lipopolysaccharide stimulation. Bone. 2018;116:279–89. https://doi.org/10.1016/j.bone.2018.08.014.

Wang Y, Zheng ZJ, Jia YJ, Yang YL, Xue YM. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. J Transl Med. 2018;16(1):146.

Yang Y, Zhang N, Wang S, Wen Y. MicroRNA-155 regulates inflammatory response in ischemic cerebral tissues through autophagy. Curr Neurovasc Res. 2018;15(2):103–10. https://doi.org/10.2174/1567202615666180601081409.

Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990, 335(8697):1078-1080.

Liang L, Tan X, Zhou Q, Zhu Y, Tian Y, Yu H, et al. IL-1beta triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behcet’s disease. Invest Ophthalmol Vis Sci. 2013;54(1):402–14. https://doi.org/10.1167/iovs.12-11047.

Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, et al. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2012;53(8):4668–75. https://doi.org/10.1167/iovs.12-9863.

Lopes de Faria JM, Duarte DA, Montemurro C, Papadimitriou A, Consonni SR, Lopes de Faria JB. Defective autophagy in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(10):4356–66.

Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 2015;282(24):4672–8. https://doi.org/10.1111/febs.13540.

Noda T. Regulation of autophagy through TORC1 and mTORC1. Biomolecules. 2017;7(3):52. https://doi.org/10.3390/biom7030052.

Wu Y, Wang X, Guo H, Zhang B, Zhang XB, Shi ZJ, et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy. 2013;9(4):595–603. https://doi.org/10.4161/auto.23641.

Etna MP, Sinigaglia A, Grassi A. Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells. PLoS Pathog. 2018;14(1):e1006790.

Liu F, Nie C, Zhao N, Wang Y, Liu Y, Li Y, et al. MiR-155 alleviates septic lung injury by inducing autophagy via inhibition of transforming growth factor-beta-activated binding protein 2. Shock. 2017;48(1):61–8.

Zarogoulidis P, Petanidis S, Domvri K, Kioseoglou E, Anestakis D, Freitag L, et al. Autophagy inhibition upregulates CD4(+) tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation. Mol Oncol. 2016;10(10):1516–31. https://doi.org/10.1016/j.molonc.2016.08.005.

Santeford A, Wiley LA, Park S, Bamba S, Nakamura R, Gdoura A, et al. Impaired autophagy in macrophages promotes inflammatory eye disease. Autophagy. 2016;12(10):1876–85. https://doi.org/10.1080/15548627.2016.1207857.

Jia X, Li J, Shi D, Zhao Y, Dong Y, Ju H, et al. Grouping annotations on the subcellular layered interactome demonstrates enhanced autophagy activity in a recurrent experimental autoimmune uveitis T cell line. Plos one. 2014;9(8):e104404. https://doi.org/10.1371/journal.pone.0104404.

Mantegazza AR, Wynosky-Dolfi MA. Increased autophagic sequestration in adaptor protein-3 deficient dendritic cells limits inflammasome activity and impairs antibacterial immunity. PLoS Pathog. 2017;13(12):e1006785.

Zang F, Chen Y, Lin Z, Cai Z, Yu L, Xu F, et al. Autophagy is involved in regulating the immune response of dendritic cells to influenza A (H1N1) pdm09 infection. Immunology. 2016;148(1):56–69. https://doi.org/10.1111/imm.12587.

Wu K, Zhu C, Yao Y, Wang X, Song J, Zhai J. MicroRNA-155-enhanced autophagy in human gastric epithelial cell in response to Helicobacter pylori. Saudi J Gastroenterol. 2016;22(1):30–6. https://doi.org/10.4103/1319-3767.173756.

Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M, et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34(4):759–67. https://doi.org/10.1161/ATVBAHA.113.302701.

Takaesu G, Kobayashi T, Yoshimura A. TGFβ-activated kinase 1 (TAK1)-binding proteins (TAB) 2 and 3 negatively regulate autophagy. J Biochem. 2012;151(2):157–66. https://doi.org/10.1093/jb/mvr123.

Criollo A, Niso-Santano M, Malik SA, Michaud M, Morselli E, Mariño G, et al. Inhibition of autophagy by TAB2 and TAB3. EMBO J. 2011;30(24):4908–20. https://doi.org/10.1038/emboj.2011.413.

Niso-Santano M, Criollo A, Malik SA, Michaud M, Morselli E, Mariño G, et al. Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway. Autophagy. 2012;8(2):268–70. https://doi.org/10.4161/auto.8.2.18845.

Paglin S, Lee NY, Nakar C, Fitzgerald M, Plotkin J, Deuel B, et al. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res. 2005;65(23):11061–70. https://doi.org/10.1158/0008-5472.CAN-05-1083.

Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005;65(8):3336–46. https://doi.org/10.1158/0008-5472.CAN-04-3640.

Okamoto T, Ozawa Y, Kamoshita M, Osada H, Toda E, Kurihara T, et al. The neuroprotective effect of rapamycin as a modulator of the mTOR-NF-kappaB axis during retinal inflammation. Plos one. 2016;11(1):e0146517. https://doi.org/10.1371/journal.pone.0146517.

Blair J, Barry R, Moore DJ, Denniston AK. A comprehensive review of mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis. Curr Pharm Des. 2017;23(20):3005–14. https://doi.org/10.2174/1381612823666170111125550.

Blair J, Barry R, Murray PI, Moore DJ, Denniston AK: mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol. Syst Rev. 2018;7(1):83.

Ibrahim MA, Sepah YJ, Watters A, Bittencourt M, Vigil EM, Do DV, et al. One-year outcomes of the SAVE study: sirolimus as a therapeutic approach for UVEitis. Transl Vis Sci Technol. 2015;4(2):4. https://doi.org/10.1167/tvst.4.2.4.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 23

1-11

Thông tin tác giả